Mechanisms of gelofusine protection in an in vitro model of polymyxin B-associated renal injury
- 1 July 2024
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 327 (1) , F137-F145
Abstract
Gelofusine is a gelatinous saline solution with the potential to attenuate polymyxin-associated nephrotoxicity. We demonstrated that the mechanisms of gelofusine renal protection involve reducing polymyxin B uptake by proximal tubule cells, limiting subsequent oxidative stress and apoptosis activation. In addition, gelofusine was more effective at reducing cellular injury than a known antioxidant control, methionine, and a megalin knockout cell line, indicating that gelofusine likely has additional pharmacological properties besides only megalin inhibition.Keywords
Funding Information
- VA Merit Award (2I01BX002006)
This publication has 23 references indexed in Scilit:
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Interactions between leucines within the signal peptides of megalin and stanniocalcin-1 are crucial for regulation of mitochondrial metabolismLaboratory Investigation, 2022
- Megalin mediates plasma membrane to mitochondria cross-talk and regulates mitochondrial metabolismCellular and Molecular Life Sciences, 2018
- Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human diseaseKidney International, 2016
- TAK1 modulates satellite stem cell homeostasis and skeletal muscle repairNature Communications, 2015
- Risk factors for nephrotoxicity onset associated with polymyxin B therapyJournal of Antimicrobial Chemotherapy, 2015
- A validated ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of polymyxin B in mouse serum and epithelial lining fluid: application to pharmacokinetic studiesJournal of Antimicrobial Chemotherapy, 2013
- Targeted ablation of TRAF6 inhibits skeletal muscle wasting in miceJournal of Cell Biology, 2010
- Polymyxin B for the treatment of multidrug-resistant pathogens: a critical reviewJournal of Antimicrobial Chemotherapy, 2007
- The gelatin-derived plasma substitute Gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorptionJournal of Critical Care, 2001